"CHICAGO--(BUSINESS WIRE)--Zacks highlights commentary from People and Picks Trader BioMO. For more Voice of the People, visit http://at.zacks.com/?id=5851 Featured Post New Pick: Cadence Pharma Candence Pharmaceuticals (Nasdaq: CADX) has an early November PDUFA date and expected FDA decision for OFIRMEV (intravenous or IV acetaminophen). CADX is developing OFIRMEV ..."

From WWW.BUSINESSWIRE.COM